Sun Pharma to acquire Concert Pharmaceuticals to bolster dermatology franchise

India-based Sun Pharmaceutical Industries (Sun Pharma) will acquire US-based Concert Pharmaceuticals for equity consideration of $576 million to strengthen its global dermatology franchise. Concert Pharmaceuticals ... Read More